Effective immediately, AmerisourceBergen Chief Operating Officer, Kurt J.
Hilzinger, will assume Mr. Martini's responsibilities in addition to his current
duties. To ensure a smooth transition, Mr. Martini is scheduled to leave the
Company at the end of September 2002. Afterward, he will remain available in a
consulting role.
Commenting on Mr. Martini's departure, R. David Yost, AmerisourceBergen
President and Chief Executive Officer said, "Brent's contributions to
AmerisourceBergen have been widespread. He has been instrumental in designing
and implementing our current organization structure, playing an integral role in
the completion of the merger. He provided excellent leadership in the critical
months immediately following the close of the transaction, and helped shape the
direction and the momentum of our new company. His energetic and enthusiastic
support of me and the total AmerisourceBergen management team is greatly
appreciated."
About AmerisourceBergen
AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in
the United States dedicated solely to the pharmaceutical supply chain. It is the
leading distributor of pharmaceutical products and services to the hospital
systems/acute care market, alternate care and mail order facilities, independent
community pharmacies, and regional chain pharmacies.
The Company is also a leader in the institutional pharmacy marketplace. With
more than $39 billion in annualized operating revenue, AmerisourceBergen is
headquartered in Valley Forge, PA, and employs more than 13,000 people serving
over 25,000 customers.
Forward-Looking Statements
This press release may contain certain "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. These statements are based on management's
current expectations and are subject to uncertainty and changes in
circumstances. Actual results may vary materially from the expectations
contained in the forward-looking statements. The forward-looking statements
herein include statements addressing future financial and operating results of
AmerisourceBergen and the benefits and other aspects of the merger between
AmeriSource Health Corporation and Bergen Brunswig Corporation.
The following factors, among others, could cause actual results to differ
materially from those described in the forward-looking statements: the risk that
the businesses of AmeriSource and Bergen Brunswig will not be integrated
successfully; failure to obtain and retain expected synergies; and other
economic, business, competitive and/or regulatory factors affecting the business
of AmerisourceBergen generally.
More detailed information about these factors is set forth in
AmerisourceBergen's filings with the Securities and Exchange Commission,
including its most recent 10-Q, its Annual Report on Form 10-K for fiscal 2001,
and AmeriSource's and Bergen's joint proxy statement-prospectus dated August 1,
2001.
AmerisourceBergen, AmeriSource and Bergen Brunswig are under no obligation to
(and expressly disclaim any such obligation to) update or alter their
forward-looking statements whether as a result of new information, future events
or otherwise.
(c) Copyright 2002 AmerisourceBergen Corporation.
AmerisourceBergen Corporation
CONTACT: AmerisourceBergen Corporation, Valley Forge
Michael N. Kilpatric, 610/727-7118
mkilpatric@amerisource.com
(c) 2002 Business Wire. All reproduction, other than for an individual user`s reference, is prohibited without prior written permission.